Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 1 Lupus Erythematosus, Systemic 1 Infections 1

Interventions

Nivolumab 2 sotrovimab 1 gusacitinib 1 ciclesonide 1 cabozantinib 1 anifrolumab 1 Standard of Care 1 Specimen Handling 1 Procalcitonin 1 Practice Guidelines as Topic 1 Platinum Compounds 1 Niclosamide 1 Methods 1 Ipilimumab 1 Interviews as Topic 1 Immune Checkpoint Inhibitors 1 High-Intensity Interval Training 1 Exercise 1 Educational Status 1 Early Intervention, Educational 1 Cholecalciferol 1 CTLA-4 Antigen 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lupus Erythematosus, Systemic × anifrolumab × Clear all

NCT07000110 2026-05-20

SIMA

AstraZeneca

Infections, Lupus Erythematosus, Systemic, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡